CPIG
ALNY icon

Chicago Partners Investment Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Chicago Partners Investment Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
+973
New +$293K 0.01% 1303
2026
Q1 		– Sell
-617
Closed -$221K – 1492
2025
Q4 		$221K Sell
617
-355
-37% -$157K 0.01% 1194
2025
Q3 		$463K Buy
+972
New +$396K 0.01% 747
2025
Q1 		– Sell
-1,022
Closed -$246K – 937
2024
Q4 		$246K Buy
+1,022
New +$269K 0.01% 736

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chicago Partners Investment Group's ALNY Position: Q2 2026 in Review

Chicago Partners Investment Group opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 973 shares worth $261K. The stake represents 0.01% of the portfolio and ranks #1303 among its holdings. This is a return to the name: Chicago Partners Investment Group previously reported a position in ALNY as recently as Q4 2025.

Chicago Partners Investment Group first reported a position in ALNY in Q4 2024 and has held it in 4 quarters since. The position peaked at $463K in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Chicago Partners Investment Group held 973 shares of Alnylam Pharmaceuticals worth $261K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Chicago Partners Investment Group position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1303 holding.
  • Chicago Partners Investment Group first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Chicago Partners Investment Group's Alnylam Pharmaceuticals position peaked at $463K in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.